CardioSomaticsCardioSomaticsCardioСоматика2221-71852658-5707Eco-Vector63030310.17816/CS630303Case reportsКлинические случаиResearch ArticleThrombosis of the superior vena cava in a patient with an implanted cardioverter–defibrillator: A case reportКлинический случай тромбоза верхней полой вены у пациентки с имплантированным кардиовертером-дефибрилляторомhttps://orcid.org/0000-0001-7021-4061572192653149256-8661ParaninaElena V.ПаранинаЕлена Владимировна
Russian Federation

MD, Cand. Sci. (Medicine), associate professor

канд. мед. наук, доцент

eles77@list.ruhttps://orcid.org/0000-0003-3501-2354571983637338085-3904LebedevPetr A.ЛебедевПётр Алексеевич
Russian Federation

MD, Dr. Sci. (Medicine), professor

доктор мед. наук, профессор

palebedev@yahoo.comhttps://orcid.org/0000-0002-7996-52133477-8758YakuninaAlbina V.ЯкунинаАльбина Викторовна
Russian Federation

MD, Cand. Sci. (Medicine), associate professor

канд. мед. наук, доцент

a.v.yakunina@samsmu.ruhttps://orcid.org/0000-0002-0520-7268ElizarovMaxim A.ЕлизаровМаксим Александрович
Russian Federation

MD

maksim.elizarov@mail.ruhttps://orcid.org/0009-0000-3990-82412902-7646ParaninPavel O.ПаранинПавел Олегович
Russian Federation

MD

paranin.po@mail.ruSamara State Medical UniversityСамарский государственный медицинский университет27082024151120241532432531304202403082024Copyright ©; 2024, Eco-VectorCopyright ©; 2024, ООО "Эко-Вектор"2024Eco-VectorООО "Эко-Вектор"https://creativecommons.org/licenses/by-nc-nd/4.0https://cardiosomatics.ru/2221-7185/article/view/630303

BACKGROUND: Superior vena cava syndrome results from the occlusion of blood flow in the superior vena cava due to external compression, internal obstruction, or infiltration of the vessel wall by a tumor. Although thrombotic complications caused by electrodes of cardiac implantable devices are uncommon in clinical practice, their incidence has been increasing due to the increasing need for such devices, which effectively correct the compromised electrical or mechanical functions of the heart chambers.

CLINICAL CASE DESCRIPTION: Herein, we have presented a case of superior vena cava thrombosis syndrome in a patient who had undergone cardioverter–defibrillator implantation for dilated cardiomyopathy. We have discussed the classification of superior vena cava syndromes, its pathogenesis, and the types of collateral circulation.

CONCLUSION: As observed in our patient, the concurrent presence of chronic heart failure syndrome can make it challenging to recognize superior vena cava syndrome in the early stages of diagnosis.

Обоснование. Синдром верхней полой вены является результатом окклюзии кровотока в ней из-за внешней компрессии, внутренней обструкции или опухолевой инфильтрации стенки сосуда. Тромботические осложнения, вызванные имплантируемыми в сердце электродами электронных устройств, до настоящего времени в клинической практике встречались нечасто, но их частота возрастает в связи с увеличением потребности в имплантации этих устройств, обеспечивающих эффективную коррекцию скомпрометированной электрической или механической функции камер сердца.

Описание клинического случая. В статье представлен случай синдрома тромбоза верхней полой вены у пациентки после имплантации кардиовертера-дефибриллятора по поводу дилатационной кардиомиопатии. Обсуждается классификация синдромов верхней полой вены, представлены типы коллатерального кровообращения, патогенез.

Заключение. Особенностью представленного случая является сочетание с синдромом хронической сердечной недостаточности, который затрудняет распознавание синдрома верхней полой вены на ранних этапах диагностики.

superior vena cava syndromevenous thrombosispacemaker/ICDelectrode-associated superior vena cava syndromeimplantable devicesсиндром верхней полой венывенозный тромбозкардиостимулятор/ИКДэлектродассоциированный синдром верхней полой веныимплантируемые устройстваShah RP, Bolaji O, Duhan S, et al. Superior Vena Cava Syndrome: An umbrella Review. Cureus. 2023;15(7):e42227. doi: 10.7759/cureus.42227Shah R.P., Bolaji O., Duhan S., et al. Superior Vena Cava Syndrome: An umbrella review // Cureus. 2023. Vol. 15, N. 7. Р. e42227. doi: 10.7759/cureus.42227Zimetbaum P, Carroll BJ, Locke AH, et al. Lead-related venous obstruction in patients with implanted cardiac devices: JACC Review Topic of the Week. J Am Coll Cardiol. 2022;79(3):299–308. doi: 10.1016/j.jacc.2021.11.017Zimetbaum P., Carroll B.J., Locke A.H., et al. Lead-related venous obstruction in patients with implanted cardiac devices: JACC Review Topic of the Week // J Am Coll Cardiol. 2022. Vol. 79, N. 3. Р. 299–308. doi: 10.1016/j.jacc.2021.11.017Locke AH, Shim DJ, Burr J, et al. Lead-associated Superior Vena Cava Syndrome. J Innov Card Rhythm Manag. 2021;12(4):4459–4465. doi: 10.19102/icrm.2021.120404Locke A.H., Shim D.J., Burr J., et al. Lead-associated Superior Vena Cava Syndrome // J Innov Card Rhythm Manag. 2021. Vol. 12, N. 4. Р. 4459–4465. doi: 10.19102/icrm.2021.120404Asif A, Salman L, Carrillo RG, et al. Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study. Semin Dial. 2009;22(6):671–676. doi: 10.1111/j.1525-139X.2009.00636.xAsif A., Salman L., Carrillo R.G., et al. Patency rates for angioplasty in the treatment of pacemaker-induced central venous stenosis in hemodialysis patients: results of a multi-center study // Semin Dial. 2009. Vol. 22, N. 6. Р. 671–676. doi: 10.1111/j.1525-139X.2009.00636.xArora Y, Carrillo RG. Lead-related superior vena cava syndrome: Management and outcomes. Heart Rhythm. 2021;18(2):207–214. doi: 10.1016/j.hrthm.2020.09.006Arora Y., Carrillo R.G. Lead-related superior vena cava syndrome: Management and outcomes // Heart Rhythm. 2021. Vol. 18, N. 2. Р. 207–214. doi: 10.1016/j.hrthm.2020.09.006Haddad MM, Simmons B, McPhail IR, et al. Comparison of covered versus uncovered stents for benign Superior Vena Cava (SVC) obstruction. Cardiovasc Intervent Radiol. 2018;41(5):712–717. doi: 10.1007/s00270-018-1906-3Haddad M.M., Simmons B., McPhail I.R., et al. Comparison of covered versus uncovered stents for benign Superior Vena Cava (SVC) obstruction // Cardiovasc Intervent Radiol. 2018. Vol. 41, N. 5. Р. 712–717. doi: 10.1007/s00270-018-1906-3Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 — a World Society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–1027. doi: 10.1111/j.1540-8159.2011.03150.xMond H.G., Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009 — a World Society of Arrhythmia’s project // Pacing Clin Electrophysiol 2011. Vol. 34, N. 8. Р. 1013–1027. doi: 10.1111/j.1540-8159.2011.03150.xRaatikainen MJP, Arnar DO, Merkely B, et al. Decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the european society of cardiology countries: 2017 Report from the European Heart Rhythm Association. Europace. 2017;19(suppl 2):1–90. doi: 10.1093/europace/eux258Raatikainen M.J.P., Arnar D.O., Merkely B., et al. Decade of information on the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the european society of cardiology countries: 2017 Report from the European Heart Rhythm Association // Europace. 2017. Vol. 19, suppl 2. Р. 1–90. doi: 10.1093/europace/eux258Chen JC, Bongard F, Klein SR. A contemporary perspective on superior vena cava syndrome. Am J Surg. 1990;160:207–211. doi: 10.1016/s0002-9610(05)80308-3Chen J.C., Bongard F., Klein S.R. A contemporary perspective on superior vena cava syndrome // Am J Surg. 1990. Vol. 160. Р. 207–211. doi: 10.1016/s0002-9610(05)80308-3Barakat K, Robinson NM, Spurrell RA. Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature. Cardiology. 2000;9(3):142–148. doi: 10.1159/000007018Barakat K., Robinson N.M., Spurrell R.A. Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature // Cardiology. 2000. Vol. 9, N. 3. Р. 142–148. doi: 10.1159/000007018Kokotsakis J, Chaudhry UA, Tassopoulos D, et al. Surgical management of superior vena cava syndrome following pacemaker lead infection: a case report and review of the literature. J Cardiothorac Surg. 2014;9:107. doi: 10.1186/1749-8090-9-107Kokotsakis J., Chaudhry U.A., Tassopoulos D., et al. Surgical management of superior vena cava syndrome following pacemaker lead infection: a case report and review of the literature // J Cardiothorac Surg. 2014. Vol. 9. Р. 107. doi: 10.1186/1749-8090-9-107Thibodeau JT, Drazner MH. The role of the clinical examination in patients with heart failure. JACC Heart Fail. 2018;6(7):543–551. doi: 10.1016/j.jchf.2018.04.005Thibodeau J.T., Drazner M.H. The role of the clinical examination in patients with heart failure // JACC Heart Fail. 2018. Vol. 6, N. 7. Р. 543–551. doi: 10.1016/j.jchf.2018.04.005Mineo TC, Ambrogi V, Nofroni I, et al. Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients. Ann Thorac Surg. 1999;68:223–226. doi: 10.1016/s0003-4975(99)00455-5Mineo T.C., Ambrogi V., Nofroni I., et al. Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients // Ann Thorac Surg. 1999. Vol. 68. Р. 223–226. doi: 10.1016/s0003-4975(99)00455-5Righini M, Aujesky D, Roy P, et al. Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism. Arch Intern Med. 2004;164(22):2483–2487. doi: 10.1001/archinte.164.22.2483Righini M., Aujesky D., Roy P., et al. Clinical usefulness of D-dimer depending on clinical probability and cutoff value in outpatients with suspected pulmonary embolism // Arch Intern Med. 2004. Vol. 164, N. 22. Р. 2483–2487. doi: 10.1001/archinte.164.22.2483Burduli NM. Superior vena cava syndrome. Klinicheskaya medicina. 2015;93(12):61–63.Бурдули Н.М. Синдром верхней полой вены // Клиническая медицина. 2015. Т. 93, № 12. С. 61–63.Kim IS, Shin HK, Kang SS, et al. Rescue of hemodynamic compromise in superior vena cava syndrome with transesophageal echocardiography. Korean J Anesthesiol. 2013;65(3):273–275. doi: 10.4097/kjae.2013.65.3.273Kim I.S., Shin H.K., Kang S.S., et al. Rescue of hemodynamic compromise in superior vena cava syndrome with transesophageal echocardiography // Korean J Anesthesiol. 2013. Vol. 65, N. 3. Р. 273–275. doi: 10.4097/kjae.2013.65.3.273